Merus (NASDAQ: MRUS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Merus (NASDAQ: MRUS) through any online brokerage.
There are no as such competitors for Merus.
The latest price target for Merus (NASDAQ: MRUS) was reported by Citigroup on Thursday, May 19, 2022. The analyst firm set a price target for 37.00 expecting MRUS to rise to within 12 months (a possible 63.43% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Merus (NASDAQ: MRUS) is $22.64 last updated Today at June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Merus.
Merus’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Merus.
Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.